Cancer Immunotherapy: Decoding the Cancer Immunity Interactome Web Banner

Web Desc
Cancer Immunotherapy: Decoding the Cancer Immunity Interactome
Scientific Organizers: Charles G. Drake, Ira Mellman and Andrea Schietinger
Date: March 20 - 24, 2022
InPerson Location: Fairmont Chateau Whistler, Whistler, BC, Canada
Meeting is available as a Livestream, click register button below for more details
Meeting is available to view On Demand, click register button below for more details
Sponsored by Genentech, Inc.
For Updated Health and Safety Guidelines for Keystone Symposia in-person meetings, click here
Summary of Meeting:
Although there has been rapid advancement in the understanding of cancer immunity, application of this evolving body of knowledge is impeded by divisions between disciplines and the challenges inherent in remaining abreast of a rapidly developing field. Widening knowledge gaps span the interface between clinical and basic data, as well as between scientists who are focused on disparate immune components of the tumor microenvironment and between systems biology, bioinformatics data and their practical application. In bringing together translational physicians, basic immunologists and cutting-edge systems biologists, this conference will foster interdisciplinary cooperation such that cutting-edge discoveries made in the bioinformatics field will help drive translation and lab-based investigation. Additionally, it will provide a showcase for novel imaging and profiling technologies, fostering their widespread adoption by the cancer immunity field as a whole. Finally, it will highlight recent advances in our understanding of epigenetic control of T cell function. A goal of the conference is to bring together these different groups of scientists and to accelerate the application of new technologies and systems biology approaches to their own research efforts. A well-organized cancer immunity conference focused on bringing together translational and basic investigation, along with cutting edge systems biology and technology approaches represents a novel construct previously not fulfilled by other, isolated silo-like meetings. The disciplines gathered for this conference would not normally co-attend meetings. This program is aimed at addressing these widening knowledge gaps which are being promulgated by a rapidly evolving field.
DEADLINES:
*All deadlines end at 11:59 PM US Mountain Standard Time
Global Health Award Deadline: February 28 2022 details
Scholarship Deadline: December 1 2021 details
Abstract Deadline: December 8 2021 details & pricing
Discounted Registration Deadline: January 20 2022 details & pricing


Keystone Symposia is committed to maintaining a positive and respectful environment at its meetings. To this end, please review and comply with our policies.


All those submitting an abstract should plan to attend in-person to ensure extensive interaction opportunities. At this time we recognize that a small percentage of submitters may be unable to travel due to border crossing restrictions and/or institutional travel bans. If these restrictions are still in place during the meeting, permissions for remote presentations will be given for the exceptional circumstances listed above.

NOTE: In the event that your abstract isn't selected for a short talk and you're not able to travel the abstract fee is nonrefundable. All paid abstracts will be included in the meeting app and meeting materials available online.


Keystone Symposia thanks our Sponsor(s) for generously supporting this meeting:
Genentech, Inc.
We gratefully acknowledge additional support from these exhibitors at this conference:
Myriad-RBM
We appreciate the organizations that provide Keystone Symposia with additional support, such as marketing and advertising:

Click here to view more of these organizations
Special thanks to the following for their support of Keystone Symposia initiatives to increase participation at this meeting by scientists from underrepresented backgrounds:

Click here to view more of these organizations

No content found

No content found

No content found

No content found